No Data
Investors in OPKO Health (NASDAQ:OPK) Have Unfortunately Lost 70% Over the Last Three Years
Form 144(Amend) | Opko Health(OPK.US) 10% Stockholder Proposes to Sell 36.49 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $Opko Health(OPK.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 1.37 million shares of its common stock on Jun 28, with a total market value of approximately $3
Form 144 | Opko Health(OPK.US) 10% Stockholder Proposes to Sell 6.96 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $Opko Health(OPK.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 261.42K shares of its common stock on Jun 28, with a total market value of approximately $6.96 m
Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?
Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Report 2024 Featuring Innate Pharma, ModeX Therapeutics, Molecular Partners, OPKO Health, Sichuan Baili Pharmaceutical, SystImmune - ResearchAndMarkets.com
Bullish OPKO Health Insiders Loaded Up On US$12.9m Of Stock